Delaware Governor Matt Meyer (D) has officially signed HB 373 into law, establishing a comprehensive regulatory framework for hemp-derived THC beverages within the state. This legislative move marks a significant shift in Delaware’s oversight of the intoxicating hemp market, moving toward a structure that mirrors many aspects of regulated cannabis commerce. The new law imposes strict age requirements, mandating that hemp-derived THC drinks may only be sold to individuals aged 21 and older.
Furthermore, the legislation introduces potency restrictions, effectively limiting the cannabinoid content allowed in these products to curb uncontrolled consumption. Beyond product safety and age-gating, the bill implements a tax structure on these beverages, bringing them into the state’s fiscal reporting system. For stakeholders, this shift signals the end of a relatively loosely regulated environment for hemp-infused beverages in Delaware.
By codifying sales requirements and potency caps, the state is aligning the hemp drink category more closely with the existing legal cannabis industry. Business owners, including dispensary operators and smoke shop retailers, must now prepare to navigate these specific compliance measures. The move is widely viewed as a regulatory stabilization effort, intended to provide consumer clarity while ensuring that age-restricted products remain out of the hands of minors.
As the state moves toward full implementation, distributors and retail operators should audit their current inventory to ensure compliance with the newly enacted potency limits and age-verification protocols. This legislation is expected to create a more formal marketplace, potentially forcing non-compliant products off shelves and establishing a standard for future product development in the region. The emphasis on taxation and standardized regulation suggests that Delaware is prioritizing the integration of hemp products into the broader legal framework rather than maintaining a distinct and unregulated silo for hemp-derived cannabinoids.